<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="pmcid: 7127693S0734-9750(17)30175-1 doi: 10.1016/j.biotechadv.2017.12.016 : Article In vitro methods for" exact="testing" post="antiviral drugs RumlováMichaelamichaela.rumlova@vscht.cza⁎RumlTomáštomas.ruml@vscht.czb⁎[a], [b], ⁎Corresponding authors. michaela.rumlova@vscht.cztomas.ruml@vscht.cz pmc-release: 2017-12-12ppub:"/>
 <result pre="of clinically important viruses. Highlights •This paper reviews methods for" exact="screening" post="new compounds targeting clinically most relevant groups of viruses."/>
 <result pre="including DNA, RNA and retroviruses. Keywords Virus Inhibitor Assay High-throughput" exact="screening" post="Method Replication Entry Assembly In vitro Cell-based 1 Introduction"/>
 <result pre="assays used for identification and evaluation of antivirotics, including high-throughput" exact="screening" post="(HTS) methods. An overview of available inhibitors and vaccines,"/>
 <result pre="that prevents viral disassembly outside the cell is lowered upon" exact="infection" post="by structural changes in the viral components. These changes"/>
 <result pre="into the cell In general, the first phase of viral" exact="infection" post="is specific recognition of the target host cell and"/>
 <result pre="2.5 Assembly Depending on the species, viruses assemble either in" exact="contact" post="with the cellular membrane or independent of the membrane"/>
 <result pre="production. Various types of vesicles that are formed upon viral" exact="infection" post="have different roles in viral replication (Rossignol et al.,"/>
 <result pre="simplest release mechanism, although the transition to lysis from latent" exact="infection" post="is delicately regulated (Aneja and Yuan, 2017, Levings and"/>
 <result pre="in the viral life cycle. 3.1 Assays and methods for" exact="screening" post="and evaluating viral entry inhibitors Different types of assays,"/>
 <result pre="the gp41 6-helix bundle but not the individual peptides, enables" exact="screening" post="for compounds that prevent formation of fusion-active gp41. For"/>
 <result pre="viral entry inhibitors. High throughput formats have been developed for" exact="screening" post="of HIV-1 fusion inhibitors. Cell-cell fusion assays involve two"/>
 <result pre="Lassa virus envelope glycoprotein, has been used for entry inhibitor" exact="screening" post="(Cheng et al., 2017). This screening identified multiple compounds"/>
 <result pre="used for entry inhibitor screening (Cheng et al., 2017). This" exact="screening" post="identified multiple compounds with potent inhibitory activity against entry"/>
 <result pre="had been limited by the lack of an in vitro" exact="infection" post="system. Several aspects of the HBV life cycle have"/>
 <result pre="for HTS of inhibitors (Yan et al., 2012). In an" exact="infection" post="competition assay, HBV particles were isolated and used to"/>
 <result pre="analysis as the number of GFP-positive cells. Use of this" exact="screening" post="system led to discovery of a triazine derivative that"/>
 <result pre="entry (Gastaminza et al., 2010). 3.2 Assays and methods for" exact="screening" post="viral capsid disassembly/uncoating inhibitors The majority of viruses enter"/>
 <result pre="HIV-1 core from a whole cell lysate prepared shortly after" exact="infection" post="(Stremlau et al., 2006). The &quot;CsA-washout assay&quot; involves specific"/>
 <result pre="&quot;CsA-washout assay&quot; involves specific cellular factors (TRIM-cyclophilin) that restrict HIV-1" exact="infection" post="by binding to the capsid core and cyclosporine A"/>
 <result pre="affect viral uncoating in vitro. 3.3 Assays and methods for" exact="screening" post="and evaluating viral genome replication inhibitors 3.3.1 Polymerases Depending"/>
 <result pre="2012), and quantitative real-time reverse-transcription PCR has become standard for" exact="screening" post="inhibitors of viral RNA polymerases (Lee et al., 2015,"/>
 <result pre="reporter genes can be used for cell-based luminescent or fluorescent" exact="screening" post="of viral inhibitors (Beadle et al., 2016, Edwards et"/>
 <result pre="inhibitors (Avila et al., 2006). Assays for luminescent and fluorescent" exact="screening" post="of ATPase activity, including an immunochemical method using fluorescently"/>
 <result pre="properties of nanoparticles due to DNA unwinding and allows simple" exact="screening" post="of inhibitor activity. The dsDNA melting curves can be"/>
 <result pre="cell (Olsen et al., 2006), they are not applicable to" exact="screening" post="inhibitors of a single viral kinase. For these purposes,"/>
 <result pre="proteins and inactivate all enzymes, respectively) are subjected to kinase" exact="treatment" post="in the presence of inhibitors (Huang et al., 2007,"/>
 <result pre="2016). Fluorescence polarization methods also can be useful for drug" exact="screening" post="[reviewed in (Hall et al., 2016)]. Other alternatives are"/>
 <result pre="2002). An elegant approach that limits the false-positive hits in" exact="screening" post="of specific kinase inhibitors is based on an in"/>
 <result pre="formats (Wang et al., 2005). 3.4 Assay and methods for" exact="screening" post="and evaluating viral assembly inhibitors The HBV capsid protein"/>
 <result pre="also became the base for several high throughput assays for" exact="screening" post="assembly inhibitors. During the last 20 years, a number"/>
 <result pre="measuring turbidity at 350 nm. 3.5 Assay and methods for" exact="screening" post="and evaluating viral maturation inhibitors Numerous viruses, including picornaviruses,"/>
 <result pre="vitro methods, including cell-based assays, that may be suitable for" exact="screening" post="of antivirotics that interfere with the key steps of"/>
 <result pre="Microbiol.72016150327721809 AkibaH.SumaokaJ.TsumotoK.KomiyamaM.Click conjugation of a binuclear terbium(III) complex for real-time" exact="detection" post="of tyrosine phosphorylationAnal. Chem.87720153834384025757507 AlirezaeiM.FlynnC.T.WoodM.R.WhittonJ.L.Pancreatic acinar cell-specific autophagy disruption"/>
 <result pre="RNA polymerase assay as a possible platform for antiviral drug" exact="testing" post="against dengueEnzym. Microb. Technol.9220162630 AndrakeM.D.SkalkaA.M.Retroviral integrase: then and nowAnnual"/>
 <result pre="inhibitorsRetrovirology14120173628583191 AouadiW.EydouxC.CoutardB.MartinB.DebartF.VasseurJ.J.ContrerasJ.M.MoriceC.QuératG.JungM.-L.CanardB.GuillemotJ.-C.DecrolyE.Toward the identification of viral cap-methyltransferase inhibitors by fluorescence" exact="screening" post="assayAntivir. Res.144201733033928676301 ArbuckleJ.H.GardinaP.J.GordonD.N.HickmanH.D.YewdellJ.W.PiersonT.C.MyersT.G.KristieT.M.Inhibitors of the histone methyltransferases EZH2/1 induce"/>
 <result pre="histone methyltransferases EZH2/1 induce a potent antiviral state and suppress" exact="infection" post="by diverse viral pathogensMBio842017 AvilaC.HaddenM.K.MaZ.KornilayevB.A.YeQ.-Z.BlaggB.S.J.High-throughput screening for Hsp90 ATPase"/>
 <result pre="antiviral state and suppress infection by diverse viral pathogensMBio842017 AvilaC.HaddenM.K.MaZ.KornilayevB.A.YeQ.-Z.BlaggB.S.J.High-throughput" exact="screening" post="for Hsp90 ATPase inhibitorsBioorg. Med. Chem. Lett.161120063005300816530412 BaldickC.J.WichroskiM.J.PendriA.WalshA.W.FangJ.MazzuccoC.E.PokornowskiK.A.RoseR.E.EggersB.J.HsuM.ZhaiW.ZhaiG.GerritzS.W.PossM.A.MeanwellN.A.CockettM.I.TenneyD.J.A novel"/>
 <result pre="model of pathogenicity and syncytium formationAIDS Res. Hum. Retrovir.10319942312338018384 CampagnolaG.GongP.PeersenO.B.High-throughput" exact="screening" post="identification of poliovirus RNA-dependent RNA polymerase inhibitorsAntivir. Res.913201124125121722674 CampbellE.M.HopeT.J.HIV-1"/>
 <result pre="and insights into Zika virus inhibitor designNucleic Acids Res.44212016105051051427915293 CarloniG.CremaA.ValliM.B.PonzettoA.ClementiM.HCV" exact="infection" post="by cell-to-cell transmission: choice or necessity?Curr. Mol. Med.1212012839522082483 CaseJ.B.AshbrookA.W.DermodyT.S.DenisonM.R.Mutagenesis"/>
 <result pre="reversible fluorescence nanoswitch based on carbon quantum dots nanoassembly for" exact="detection" post="of pyrophosphate ionSensors Actuators B Chem.2202015138145 Chen, Y., Cai,"/>
 <result pre="in sphingosine kinase 1 influences the susceptibility to dengue virus" exact="infection" post="by altering antiviral responsesJ. General Virol.971201695109 ClementzM.A.ChenZ.BanachB.S.WangY.SunL.RatiaK.Baez-SantosY.M.WangJ.TakayamaJ.GhoshA.K.LiK.MesecarA.D.BakerS.C.Deubiquitinating and interferon"/>
 <result pre="ebola, hendra, and nipah viruses by using a novel high-throughput" exact="screening" post="assayJ. Virol.88820144353436524501399 EngelmanA.CherepanovP.Retroviral integrase structure and DNA recombination mechanismMicrobiol."/>
 <result pre="Health/Lippincott Williams &amp;amp; WilkinsPhiladelphia FooteB.S.SpoonerL.M.BelliveauP.P.Boceprevir: a protease inhibitor for the" exact="treatment" post="of chronic Hepatitis CAnn. Pharmacother.45920111085109321828346 FreedE.O.Viral late domainsJ. Virol.761020024679468711967285"/>
 <result pre="vitro assembly of hepatitis C virus core protein and for" exact="screening" post="of inhibitorsAnal. Biochem.36612007374517493576 FujiiK.HurleyJ.H.FreedE.O.Beyond Tsg101: the role of Alix"/>
 <result pre="bovine adenovirus 3-encoded pVIIIJ. Virol.91102017 GanX.WangH.YuY.YiW.ZhuS.LiE.LiangY.Epigenetically repressing human cytomegalovirus lytic" exact="infection" post="and reactivation from latency in THP-1 model by targeting"/>
 <result pre="progress in the development of HIV-1 protease inhibitors for the" exact="treatment" post="of HIV/AIDSJ. Med. Chem.591120165172520826799988 GibsonW.Structure and formation of the"/>
 <result pre="formation of the cytomegalovirus virionCurr. Top. Microbiol. Immunol.325200818720418637507 GlebeD.AliakbariM.KrassP.KnoopE.V.ValeriusK.P.GerlichW.H.Pre-s1 antigen-dependent" exact="infection" post="of Tupaia hepatocyte cultures with human hepatitis B virusJ."/>
 <result pre="enzymes using rhodamine-based fluorogenic substratesJ. Biomol. Screen.76200253154014599351 GriponP.DiotC.ThezeN.FourelI.LorealO.BrechotC.Guguen-GuillouzoC.Hepatitis B virus" exact="infection" post="of adult human hepatocytes cultured in the presence of"/>
 <result pre="virusProc. Natl. Acad. Sci.99242002156551566012432097 GriponP.CannieI.UrbanS.Efficient inhibition of Hepatitis B Virus" exact="infection" post="by acylated peptides derived from the large viral surface"/>
 <result pre="structure diversityIran. J. Pharmaceut. Res.1542016595628 HallM.D.YasgarA.PeryeaT.BraistedJ.C.JadhavA.SimeonovA.CoussensN.P.Fluorescence polarization assays in high-throughput" exact="screening" post="and drug discovery: a reviewMethods Appl. Fluorescence422016022001 HallenbergerS.BoschV.AnglikerH.ShawE.KlenkH.-D.GartenW.Inhibition of"/>
 <result pre="fusion assay system with inducible gp160 expressionJ. Biomol. Screen.1112006657416314403 JiangS.LinK.ZhangL.DebnathA.K.A" exact="screening" post="assay for antiviral compounds targeted to the HIV-1 gp41"/>
 <result pre="3rd, Jonsson, C.B., 2005. Development and application of a high-throughput" exact="screening" post="assay for HIV-1 integrase enzyme activities. J. Biomol. Screen."/>
 <result pre="the pathogenicity of herpes simplex virus type-1Uirusu6612016839028484184 KatoT.DateT.MurayamaA.MorikawaK.AkazawaD.WakitaT.Cell culture and" exact="infection" post="system for hepatitis C virusNat. Protoc.1520062334233917406476 KatzR.A.MerkelG.KulkoskyJ.LeisJ.SkalkaA.M.The avian retroviral"/>
 <result pre="(HBV) in stably transfected hepatoblastoma cells: a novel system for" exact="screening" post="potential inhibitors of HBV replicationAntimicrob. Agents Chemother.4181997171517209257747 LaiJ.K.F.SamI.C.ChanY.F.The autophagic"/>
 <result pre="LeeH.KimY.-P.Fluorescent and bioluminescent nanoprobes for in vitro and in vivo" exact="detection" post="of matrix metalloproteinase activityBMB Rep.486201531331825817215 LeeH.MittalA.PatelK.GatuzJ.L.TruongL.TorresJ.MulhearnD.C.JohnsonM.E.Identification of novel drug"/>
 <result pre="N-terminal domain of the viral CA proteinJ. Virol.861220126643665522496222 LeuchowiusK.-J.JarviusM.WickströmM.RickardsonL.LandegrenU.LarssonR.SöderbergO.FryknäsM.JarviusJ.High content" exact="screening" post="for inhibitors of protein interactions and post-translational modifications in"/>
 <result pre="primary cells by proximity ligationMol. Cell. Proteomics91201017818319864249 LeungK.-H.HeH.-Z.HeB.ZhongH.-J.LinS.WangY.-T.MaD.-L.LeungC.-H.Label-free luminescence switch-on" exact="detection" post="of hepatitis C virus NS3 helicase activity using a"/>
 <result pre="and reveal mutations that affect mRNA cap methylationJ. Virol.81820074104411517301155 LiY.XieW.FangG.Fluorescence" exact="detection" post="techniques for protein kinase assayAnal. Bioanal. Chem.390820082049205718340436 LiX.DengD.XueJ.QuL.AchilefuS.GuY.Quantum dots"/>
 <result pre="dots based molecular beacons for in vitro and in vivo" exact="detection" post="of MMP-2 on tumorBiosens. Bioelectron.61201451251824951921 LiangY.VogelJ.L.NarayananA.PengH.KristieT.M.Inhibition of the histone"/>
 <result pre="buddingFutur. Virol.542010481491 LiuS.Boyer-ChatenetL.LuH.JiangS.Rapid and automated fluorescence-linked immunosorbent assay for high-throughput" exact="screening" post="of HIV-1 fusion inhibitors targeting gp41J. Biomol. Screen.86200368569314711394 LoM.K.JordanR.ArveyA.SudhamsuJ.Shrivastava-RanjanP.HotardA.L.FlintM.McMullanL.K.SiegelD.ClarkeM.O.MackmanR.L.HuiH.C.PerronM.RayA.S.CihlarT.NicholS.T.SpiropoulouC.F.GS-5734"/>
 <result pre="with a digital image analysis system (DIAS): application for rapid" exact="screening" post="of HIV-1 fusion inhibitorsJ. Virol. Methods1072200315516112505629 LuL.LiuQ.ZhuY.ChanK.-H.QinL.LiY.WangQ.ChanJ.F.-W.DuL.YuF.MaC.YeS.YuenK.-Y.ZhangR.JiangS.Structure-based discovery of"/>
 <result pre="for integrase activityMethods (San Diego, Calif.)4742009243248 MestasS.P.SholdersA.J.PeersenO.B.A fluorescence polarization based" exact="screening" post="assay for nucleic acid polymerase elongation activityAnal. Biochem.3652200719420017475199 MeyerN.O.O’DonoghueA.J.Schulze-GahmenU.RavalinM.MossS.M.WinterM.B.KnudsenG.M.CraikC.S.Multiplex"/>
 <result pre="OshimaM.GotoN.SusantoJ.P.MotomizuS.Determination of phosphate as aggregates of ion associates by light-scattering" exact="detection" post="and application to flow injectionAnalyst1218199610851088 ÖzeşA.R.FeoktistovaK.AvanzinoB.C.BaldwinE.P.FraserC.S.Real-time fluorescence assays to"/>
 <result pre="Enzyme Inhibition Med. Chem.321201710911101 PetersenJ.DandriM.MierW.LutgehetmannM.VolzT.von WeizsackerF.HaberkornU.FischerL.PollokJ.M.ErbesB.SeitzS.UrbanS.Prevention of hepatitis B virus" exact="infection" post="in vivo by entry inhibitors derived from the large"/>
 <result pre="occludin is a hepatitis C virus entry factor required for" exact="infection" post="of mouse cellsNature4577231200988288619182773 PodanyA.T.ScarsiK.K.FletcherC.V.Comparative clinical pharmacokinetics and pharmacodynamics of"/>
 <result pre="SchmiedelD.TaiJ.Levi-SchafferF.DovratS.MandelboimO.Human Herpesvirus 6B downregulates expression of activating ligands during lytic" exact="infection" post="to escape elimination by natural killer cellsJ. Virol.902120169608961727535049 SchwartzJ.J.QuakeS.R.Single"/>
 <result pre="terbium(III) complexesInt. J. Analytical Chem.201620163216523 SunY.WangZ.TaoJ.WangY.WuA.YangZ.WangK.ShiL.ChenY.GuoD.Yeast-based assays for the high-throughput" exact="screening" post="of inhibitors of coronavirus RNA cap guanine-N7-methyltransferaseAntivir. Res.104201415616424530452 SureauC.Romet-LemonneJ.-L.MullinsJ.I.EssexM.Production"/>
 <result pre="replicationNat. Rev. Microbiol.103201216517722266782 TscherneD.M.ManicassamyB.Garcia-SastreA.An enzymatic virus-like particle assay for sensitive" exact="detection" post="of virus entryJ. Virol. Methods1632201033634319879300 UdukalaD.N.WangH.WendelS.O.MalalasekeraA.P.SamarakoonT.N.YapaA.S.AbayaweeraG.BaselM.T.MaynezP.OrtegaR.ToledoY.BossmannL.RobinsonC.JanikK.E.KoperO.B.LiP.MotamediM.HigginsD.A.GadburyG.ZhuG.TroyerD.L.BossmannS.H.Early breast cancer screening"/>
 <result pre="sensitive detection of virus entryJ. Virol. Methods1632201033634319879300 UdukalaD.N.WangH.WendelS.O.MalalasekeraA.P.SamarakoonT.N.YapaA.S.AbayaweeraG.BaselM.T.MaynezP.OrtegaR.ToledoY.BossmannL.RobinsonC.JanikK.E.KoperO.B.LiP.MotamediM.HigginsD.A.GadburyG.ZhuG.TroyerD.L.BossmannS.H.Early breast cancer" exact="screening" post="using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detectionBeilstein"/>
 <result pre="based strategies to study receptor tyrosine kinasesIUCrJ4Pt 22017119130 WangY.KlockH.YinH.WolffK.BiezaK.NiswongerK.MatzenJ.GundersonD.HaleJ.LesleyS.KuhenK.CaldwellJ.BrinkerA.Homogeneous high-throughput" exact="screening" post="assays for HIV-1 integrase 3β-processing and strand transfer activitiesJ."/>
 <result pre="strand transfer activitiesJ. Biomol. Screen.105200545646216093555 WangH.UdukalaD.N.SamarakoonT.N.BaselM.T.KalitaM.AbayaweeraG.ManawaduH.MalalasekeraA.RobinsonC.VillanuevaD.MaynezP.BossmannL.RiedyE.BarrigaJ.WangN.LiP.HigginsD.A.ZhuG.TroyerD.L.BossmannS.H.Nanoplatforms for highly sensitive fluorescence" exact="detection" post="of cancer-related proteasesPhotochem. Photobiol. Sci.132201423124024096539 WangY.-W.LiuS.-B.YangY.-L.WangP.-Z.ZhangA.-J.PengY.A Terbium(III)-complex-based on–off fluorescent"/>
 <result pre="anti-coronavirus drug designSci. Rep.6226772016 WangX.TangS.SongX.RongL.Mathematical analysis of an HIV latent" exact="infection" post="model including both virus-to-cell infection and cell-to-cell transmissionJ. Biol."/>
 <result pre="analysis of an HIV latent infection model including both virus-to-cell" exact="infection" post="and cell-to-cell transmissionJ. Biol. Dyn.11sup2201745548327730851 WeissS.Measuring conformational dynamics of"/>
 <result pre="antibodies broadly reactive against phosphorylated motifsJ. Biol. Chem.277422002393793938712151408 ZhangZ.YangE.HuC.ChengH.ChenC.Y.HuangD.WangR.ZhaoY.RongL.VignuzziM.ShenH.ShenL.ChenZ.W.Cell-based high-throughput" exact="screening" post="assay identifies 2′,2′-difluoro-2′-deoxycytidine gemcitabine as a potential antipoliovirus agentACS"/>
 <result pre="Zika virus full-length NS5 proteinNat. Commun.820171476228345656 ZhongJ.GastaminzaP.ChengG.KapadiaS.KatoT.BurtonD.R.WielandS.F.UprichardS.L.WakitaT.ChisariF.V.Robust hepatitis C virus" exact="infection" post="in vitroProc. Natl. Acad. Sci. U. S. A.1022620059294929915939869 ZhouY.AgudeloJ.LuK.GoetzD.H.HansellE.ChenY.T.RoushW.R.McKerrowJ.CraikC.S.AmbergS.M.SimmonsG.Inhibitors"/>
 <result pre="novel DNA polymerase activity assay enabling sensitive, quantitative and universal" exact="detection" post="of viable microbesNucleic Acids Res.40142012e10922495933 Acknowledgements This work was"/>
</results>
